医药生物行业跨市场周报:打造生物医药国家队 国资药企有望价值重估

光大证券
Sep 08, 2025

行情回顾:上周,A 股医药生物上涨1.40%,跑赢沪深300 指数2.21pp,跑赢创业板综指1.71pp,在31 个子行业中排名第4。H 股恒生医疗健康指数上周收涨6.99%,跑赢恒生国企指数5.76pp。上市公司研发进度跟踪:上周,映恩生物的注射用DB-1418、信达生物的IBI3033和注射用IBI354 的临床申请新进承办;信立泰SAL0139 片、恒瑞医药的HRS-8364 片和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10